Kaiser Peter, Chief Development Officer at Ocular Therapeutix ($OCUL), made five open market sales of company shares over the past year, totaling over $223,000. His most recent sale occurred on February 23, 2026. These transactions rank 8,187th among 11,678 insiders in our database, where the average sale amount hits $8.6 million across about 6.4 trades per person. Peter recorded no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Kaiser Peter | Chief Development Officer | S | Common Stock | 2810 | $8.28 | 269,108.0000 | 187,241,483 | 1.03% | 0.00% |
| Jan. 2, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Kaiser Peter | Chief Development Officer | A | Stock Option (Right to Buy) | 240932 | $0.00 | 240,932.0000 | 187,241,483 | 9999.99% | 0.13% |
| Jan. 2, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Kaiser Peter | Chief Development Officer | A | Common Stock | 79112 | $0.00 | 271,918.0000 | 187,241,483 | 41.03% | 0.04% |
| Nov. 24, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Kaiser Peter | Chief Development Officer | S | Common Stock | 3007 | $12.02 | 191,433.0000 | 183,919,808 | 1.55% | 0.00% |
| Oct. 2, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Kaiser Peter | Chief Development Officer | S | Common Stock | 9653 | $11.03 | 194,440.0000 | 183,919,808 | 4.73% | 0.01% |
| Aug. 25, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Kaiser Peter | Chief Development Officer | S | Common Stock | 3011 | $12.04 | 204,093.0000 | 172,594,662 | 1.45% | 0.00% |
| May 23, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Kaiser Peter | Chief Development Officer | S | Common Stock | 2974 | $7.17 | 207,104.0000 | 169,396,989 | 1.42% | 0.00% |
| Feb. 24, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Kaiser Peter | Chief Development Officer | S | Common Stock | 3009 | $6.87 | 210,078.0000 | 158,265,162 | 1.41% | 0.00% |
| Nov. 25, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Kaiser Peter | Chief Development Officer | S | Common Stock | 2897 | $9.01 | 213,087.0000 | 166,992,735 | 1.34% | 0.00% |
| Oct. 2, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Kaiser Peter | Chief Development Officer | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 166,992,735 | 9999.99% | 0.12% |
| Oct. 2, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Kaiser Peter | Chief Development Officer | A | Common Stock | 100000 | $0.00 | 215,984.0000 | 166,992,735 | 86.22% | 0.06% |